Clinical Trial Update: Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of haploidentical hematopoietic cell transplantation for children with myelodysplasia and hematologic malignancies is active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Myelodysplastic Syndromes

Drugs mentioned

• Haploidentical Hematopoietic Cell Transplantation (haploidentical hematopoietic cell transplantation)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Myelodysplasia, Hematologic Malignancy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING